Nuveen, LLC Collegium Pharmaceutical, Inc Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Nuveen, LLC holds 89,566 shares of COLL stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
89,566Holding current value
$2.49 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
251Shares Held
35.4MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$161 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$73.3 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$65.3 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$62.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$46.2 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $948M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...